Novonix (NVX) Non-Current Deffered Revenue (2021 - 2025)

Novonix (NVX) has reported Non-Current Deffered Revenue for 5 consecutive years, with $146475.0 the latest figure, recorded in Q4 2025.

• Quarterly Non-Current Deffered Revenue fell 95.12% year-over-year to $146475.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $146475.0 (down 95.12% YoY) and the FY2025 annual result came in at $146475.0, down 95.12% from the prior year.
• Non-Current Deffered Revenue eased to $146475.0 in Q4 2025 per NVX's latest filing, from $3.5 million in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for NVX reached as high as $3.5 million in Q2 2025 and fell as low as $146475.0 in Q4 2025.
• A 5-year average of $2.5 million and a median of $3.0 million in 2023 frame the typical range for Non-Current Deffered Revenue.
• Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue surged 1304.81% — and 2025, when it tumbled 95.12%.
• Year by year, Non-Current Deffered Revenue stood at $2.9 million in 2021, then climbed by 12.62% to $3.3 million in 2022, then decreased by 8.68% to $3.0 million in 2023, then changed by 0.0% to $3.0 million in 2024, then slumped by 95.12% to $146475.0 in 2025.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $146475.0, $3.5 million, and $3.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.